Cargando…
Immunological combination treatment holds the key to improving survival in pancreatic cancer
Advances in surgery, peri-operative care and systemic chemotherapy have not significantly improved the prognosis of pancreatic cancer for several decades. Early clinical trials of immunotherapy have yielded disappointing results proposing other means by which the tumour microenvironment serves to de...
Autores principales: | Sodergren, M. H., Mangal, N., Wasan, H., Sadanandam, A., Balachandran, V. P., Jiao, L. R., Habib, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519893/ https://www.ncbi.nlm.nih.gov/pubmed/32748119 http://dx.doi.org/10.1007/s00432-020-03332-5 |
Ejemplares similares
-
Pancreatic Alpha Cells Hold the Key to Survival
por: Wali, Jibran A., et al.
Publicado: (2015) -
A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation
por: Lawrence, Patrick V., et al.
Publicado: (2022) -
Cannabinoids in the landscape of cancer
por: Mangal, Nagina, et al.
Publicado: (2021) -
Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?
por: Damilakis, Emmanouil, et al.
Publicado: (2020) -
COVID-19 and the Heart: ACE2 Level and the Company it Keeps Hold the Key
por: Lin, Han-Bin, et al.
Publicado: (2020)